Ropack Spring Show Guide - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ropack Spring Show Guide


Ropack provides contract packaging and manufacturing services for more than 90 U.S., Canadian and European pharmaceutical and consumer healthcare customers. Flexible, responsive and competitive, we focus on reliably accelerating the go-to-market timeline. Our 250,000 square feet of production, warehousing and distribution space includes a 15,000-square-foot, $9M facility for stick-pack packaging of humidity- and temperature-sensitive products. Because of taste-masking and convenience – without compromising integrity – stick-pack is ideal for uni-dose pediatric powders.

E-mail: Paul.dupont@ropack.com

Website: www.ropack.com

Shows attending:

  • BIO — Quebec Pavilion
  • INTERPHEX — booth 1166
  • AAPS Biotech — booth 3649

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here